Review article · 2017 · Open access
Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia
Cochrane Database of Systematic Reviews, 2017(3), CD006324 · Published 23 March 2017 · DOI 10.1002/14651858.cd006324.pub3
In brief
“Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia” is a 2017 review article by Sarah Barber and 3 co-authors, published in Cochrane Database of Systematic Reviews. OpenAlex counts 170 citations as of 20 November 2026, which puts it in the top 8% of works published in 2017 by citations. It is open access: the full text is free to read at Cochrane Database of Systematic Reviews.
- Citations
- 170
- Most cited in
- 2019 (16)
- Field-weighted impact
- 1.56
- References
- 113
- Authors
- 4
Abstract
BACKGROUND: Between 40% and 70% of people with treatment-resistant schizophrenia do not respond to clozapine, despite adequate blood levels. For these people, a number of treatment strategies have emerged, including the prescription of a second anti-psychotic drug in combination with clozapine. OBJECTIVES: To determine the clinical effects of various clozapine combination strategies with antipsychotic drugs in people with treatment-resistant schizophrenia both in terms of efficacy and tolerability. SEARCH METHODS: We searched the Cochrane Schizophrenia Group's Study-Based Register of Trials (to 28 August 2015) and MEDLINE (November 2008). We checked the reference lists of all identified randomised controlled trials (RCT). For the first version of the review, we also contacted pharmaceutical companies to identify further trials. SELECTION CRITERIA: We included only RCTs recruiting people of both sexes, aged 18 years or more, with a diagnosis of treatment-resistant schizophrenia (or related disorders) and comparing clozapine plus another antipsychotic drug with clozapine plus a different antipsychotic drug. DATA COLLECTION AND ANALYSIS: We extracted data independently. For dichotomous data, we calculated risk ratios (RRs) and 95% confidence intervals (CI) on an intention-to-treat basis using a random-effects meta-analysis. For continuous data, we calculated mean differences (MD) and 95% CIs. We used GRADE to create 'Summary of findings' tables and assessed risk of bias for included studies. MAIN RESULTS: We identified two further studies with 169 participants that met our inclusion criteria. This review now includes five studies with 309 participants. The quality of evidence was low, and, due to the high degree of heterogeneity between studies, we were unable to undertake a formal meta-analysis to increase the statistical power.For this update, we specified seven main outcomes of interest: clinical response in mental state (clinically significant response, mean score/change in mental state), clinical response in global state (mean score/change in global state), weight gain, leaving the study early (acceptability of treatment), service utilisation outcomes (hospital days or admissions to hospital) and quality of life.We found some significant differences between clozapine combination strategies for global and mental state (clinically significant response and change), and there were data for leaving the study early and weight gain. We found no data for service utilisation and quality of life. Clozapine plus aripiprazole versus clozapine plus haloperidolThere was no long-term significant difference between aripiprazole and haloperidol combination strategies in change of mental state (1 RCT, n = 105, MD 0.90, 95% CI -4.38 to 6.18, low quality evidence). There were no adverse effect data for weight gain but there was a benefit of aripiprazole for adverse effects measured by the LUNSERS…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Barber, S., Olotu, U., Corsi, M., & Cipriani, A. (2017). Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Cochrane Database of Systematic Reviews, 2017(3), CD006324. https://doi.org/10.1002/14651858.cd006324.pub3
MLA 9
Barber, Sarah, et al. “Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.” Cochrane Database of Systematic Reviews, vol. 2017, no. 3, 2017, p. CD006324. https://doi.org/10.1002/14651858.cd006324.pub3.
Chicago
Barber, Sarah, Uwaila Olotu, Martina Corsi, and Andrea Cipriani. 2017. “Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.” Cochrane Database of Systematic Reviews 2017 (3): CD006324. https://doi.org/10.1002/14651858.cd006324.pub3.
Harvard
Barber, S. et al. (2017) ‘Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia’, Cochrane Database of Systematic Reviews, 2017(3), p. CD006324. doi:10.1002/14651858.cd006324.pub3.
IEEE
S. Barber, U. Olotu, M. Corsi, and A. Cipriani, “Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia,” Cochrane Database of Systematic Reviews, vol. 2017, no. 3, p. CD006324, 2017, doi: 10.1002/14651858.cd006324.pub3.
BibTeX
@article{barber2017clozapine,
title = {{Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia}},
author = {Barber, Sarah and Olotu, Uwaila and Corsi, Martina and Cipriani, Andrea},
journal = {Cochrane Database of Systematic Reviews},
year = {2017},
volume = {2017},
number = {3},
pages = {CD006324},
doi = {10.1002/14651858.cd006324.pub3},
url = {https://doi.org/10.1002/14651858.cd006324.pub3}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 7 | |
| 2018 | 11 | |
| 2019 | 16 | |
| 2020 | 13 | |
| 2021 | 10 | |
| 2022 | 11 | |
| 2023 | 8 | |
| 2024 | 5 | |
| 2025 | 9 | |
| 2026 | 11 |
Its field-weighted citation impact is 1.56: it has been cited 1.56 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- treatment-resistant schizophrenia
- antipsychotic polypharmacy
- aripiprazole
- haloperidol
- olanzapine
- risperidone
- quetiapine
- weight gain
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Barber, S., Olotu, U., Corsi, M., & Cipriani, A. (2017). Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Cochrane Database of Systematic Reviews, 2017(3), CD006324. https://doi.org/10.1002/14651858.cd006324.pub3
How many times has this paper been cited?
170 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Cochrane Database of Systematic Reviews: sign in and open the PDF from this page.
Who wrote this paper?
Sarah Barber, Uwaila Olotu, Martina Corsi, Andrea Cipriani.
What is the DOI of this paper?
10.1002/14651858.cd006324.pub3, permanently at https://doi.org/10.1002/14651858.cd006324.pub3. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.